President Donald Trump on Tuesday announced the U.S. government will purchase 100 million doses of Moderna’s experimental coronavirus vaccine, which is currently in late-stage human trials.

Moderna separately said the deal for its vaccine, mRNA-1273, is worth $1.53 billion and will give the federal government the option to purchase up to 400 million additional doses. The U.S. has already invested $955 million in Moderna’s vaccine development, bringing its total investment up to $2.48 billion, the company said in a press release Tuesday.

Moderna’s coronavirus vaccine is in late-stage human trials, which will test its efficacy and safety in 30,000 people. The Massachusetts-based company previously said it could expect results as early as October.

The U.S. government’s deal with Moderna follows similar agreements it’s made with pharmaceutical giants Pfizer, Johnson and Johnson and other drug makers for their potential Covid-19 vaccines.

“We are investing in the development …continued .
[Source: CNBC News]